| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |